3O2F
Structure of the N-domain of GRP94 bound to the HSP90 inhibitor PU-H54
3O2F の概要
エントリーDOI | 10.2210/pdb3o2f/pdb |
関連するPDBエントリー | 2FWY 3O0I |
分子名称 | Endoplasmin, 8-[(2,4-dimethylphenyl)sulfanyl]-3-pent-4-yn-1-yl-3H-purin-6-amine, ISOPROPYL ALCOHOL, ... (5 entities in total) |
機能のキーワード | hsp90 heat-shock proteins, chaperone-inhibitor complex, chaperone/inhibitor |
由来する生物種 | Canis lupus familiaris (dogs) 詳細 |
細胞内の位置 | Endoplasmic reticulum lumen: P41148 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 54035.38 |
構造登録者 | |
主引用文献 | Patel, P.D.,Yan, P.,Seidler, P.M.,Patel, H.J.,Sun, W.,Yang, C.,Que, N.S.,Taldone, T.,Finotti, P.,Stephani, R.A.,Gewirth, D.T.,Chiosis, G. Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2. Nat.Chem.Biol., 9:677-684, 2013 Cited by PubMed Abstract: Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood. This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable. Here we combine compound library screening with structural and computational analyses to identify purine-based chemical tools that are specific for Hsp90 paralogs. We show that Grp94 selectivity is due to the insertion of these compounds into a new allosteric pocket. We use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations. Finally, we provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers. PubMed: 23995768DOI: 10.1038/nchembio.1335 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
